Bruno Lorusso

Parma, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 20 publications

PYGO2 is overexpressed in multiple myeloma patients with 1q21 amplification, driving plasma cell proliferation and cell cycle progression.

PYGO2 is overexpressed in multiple myeloma patients with 1q21 amplification, driving plasma cell proliferation and cell cycle progression.

Journal: Cancer gene therapy

Published: November 27, 2025

Inhibition of the Atypical Kinase WNK1 as a Therapeutic Strategy in TAL-related T-cell Acute Lymphoblastic Leukemia.

Inhibition of the Atypical Kinase WNK1 as a Therapeutic Strategy in TAL-related T-cell Acute Lymphoblastic Leukemia.

Journal: Blood

Published: June 27, 2025

Genetics of Darier's Disease: New Insights into Pathogenic Mechanisms.

Genetics of Darier's Disease: New Insights into Pathogenic Mechanisms.

Journal: Genes

Published: April 30, 2025

CD26 Is Differentially Expressed throughout the Life Cycle of Infantile Hemangiomas and Characterizes the Proliferative Phase.

CD26 Is Differentially Expressed throughout the Life Cycle of Infantile Hemangiomas and Characterizes the Proliferative Phase.

Journal: International journal of molecular sciences

Published: July 09, 2024

Longitudinal Blood Immune-Inflammatory and Radiomic Profiling to Decode Different Patterns of Acquired Resistance to Immunotherapy in Patients with NSCLC.

Longitudinal Blood Immune-Inflammatory and Radiomic Profiling to Decode Different Patterns of Acquired Resistance to Immunotherapy in Patients with NSCLC.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: June 21, 2024

CAD204520 Targets NOTCH1 PEST Domain Mutations in Lymphoproliferative Disorders.

CAD204520 Targets NOTCH1 PEST Domain Mutations in Lymphoproliferative Disorders.

Journal: International journal of molecular sciences

Published: November 19, 2023

Orthogonal proteogenomic analysis identifies the druggable PA2G4-MYC axis in 3q26 AML.

Orthogonal proteogenomic analysis identifies the druggable PA2G4-MYC axis in 3q26 AML.

Journal: Nature communications

Published: February 03, 2023

Integrated MRI-Immune-Genomic Features Enclose a Risk Stratification Model in Patients Affected by Glioblastoma.

Integrated MRI-Immune-Genomic Features Enclose a Risk Stratification Model in Patients Affected by Glioblastoma.

Journal: Cancers

Published: May 26, 2022

Β-blockers activate autophagy on infantile hemangioma-derived endothelial cells in vitro.

Β-blockers activate autophagy on infantile hemangioma-derived endothelial cells in vitro.

Journal: Vascular pharmacology

Published: May 24, 2022

Identification of an Epi-metabolic dependency on EHMT2/G9a in T-cell acute lymphoblastic leukemia.

Identification of an Epi-metabolic dependency on EHMT2/G9a in T-cell acute lymphoblastic leukemia.

Journal: Cell death & disease

Published: January 25, 2022

Validation of a radiomic approach to decipher NSCLC immune microenvironment in surgically resected patients.

Validation of a radiomic approach to decipher NSCLC immune microenvironment in surgically resected patients.

Journal: Tumori

Published: March 18, 2021

Dataset on the identification of a prognostic radio-immune signature in surgically resected Non Small Cell Lung Cancer.

Dataset on the identification of a prognostic radio-immune signature in surgically resected Non Small Cell Lung Cancer.

Journal: Data in brief

Published: May 05, 2020

Showing 1-12 of 20

Last Updated: 09/26/2026